IRP
TMDX icon

Investment Research Partners’s Transmedics TMDX Stock Holding History

Investment Research Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$383K Buy
5,765
+1,413
+32% +$120K 0.13% 179
2026
Q1 		$433K Buy
4,352
+386
+10% +$50.3K 0.18% 132
2025
Q4 		$482K Buy
3,966
+18
+0.5% +$2.26K 0.21% 114
2025
Q3 		$530K Buy
+3,948
New +$462K 0.24% 101

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Investment Research Partners's TMDX Position: Q2 2026 in Review

Investment Research Partners increased its Transmedics (TMDX) stake by 32% in Q2 2026, buying an estimated $120K and bringing the position to 5,765 shares worth $383K. The position accounts for 0.13% of the portfolio, ranked #179.

Investment Research Partners first reported a position in TMDX in Q3 2025 and has held it in 4 quarters since. The position peaked at $530K in Q3 2025. 240 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Investment Research Partners held 5,765 shares of Transmedics worth $383K as of Q2 2026.
  • Investment Research Partners bought 1,413 Transmedics shares in Q2 2026, an estimated $120K.
  • Transmedics made up 0.13% of Investment Research Partners's portfolio in Q2 2026, its #179 holding.
  • Investment Research Partners first reported a position in Transmedics in Q3 2025 and has held it in 4 quarters since.
  • Investment Research Partners's Transmedics position peaked at $530K in Q3 2025.
  • 240 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Investment Research Partners's 13F filing for Q2 2026, filed 4 Aug 2026.